FerriIridium: A Lysosome‐Targeting Iron(III)‐Activated Iridium(III) Prodrug for Chemotherapy in Gastric Cancer Cells

Reported is the Fe^III‐activated lysosome‐targeting prodrug FerriIridium for gastric cancer theranostics. It contains a meta‐imino catechol group that can selectively bond to, and be oxidized by, free Fe^III inside the cell. Subsequent oxidative rearrangement releases Fe^II and hydrolyses the amine bond under acidic conditions, forming an aminobipyridyl Ir complex and 2‐hydroxybenzoquinone. Thus, Fe^II catalyzes the Fenton reaction, transforming hydrogen peroxide into hydroxyl radicals, the benzoquinone compounds interfere with the respiratory chain, and conversion of the prodrug into the Ir complex leads to an increase in phosphorescence and toxicity. These properties, combined with the high Fe^III content and acidity of cancer cells, make FerriIridium a selective and efficient theranostic agent (IC₅₀=9.22 μm for AGS cells vs. >200 μm for LO2 cells). FerriIridium is the first metal‐based compound that has been developed for chemotherapy using Fe^III to enhance both selectivity and potency.     

Inclusion Complex of Podophyllotoxin with γ‐Cyclodextrin: Preparation,Characterization, Anticancer Activity,Water‐Solubility and Toxicity

An inclusion complex of podophyllotoxin (PPT) with γ‐cyclodextrin (γ‐CD) was prepared. The behavior, characterization, and water solubility of the inclusion complex were carefully investigated via fluorescence spectroscopy, thermogravimetry, differential scanning calorimetry, X‐ray diffraction analysis, and ¹H and 2D nuclear magnetic resonance spectroscopy. Furthermore, antitumor activity to human cancer lines and toxicity in mice were studied. Results showed that the inclusion complex formed in a 1:1 ratio with a considerable apparent stability constant K_s (4245.5 L·mol^?1). Water solubility was considerably improved. In addition, the anticancer activity of the inclusion complex was better than that of cis‐platinum (DDP, positive control). Most importantly, the toxicity of podophyllotoxin inclusion complex reduced and became more safety to mice which will be great valuable to research its applications as a kind of antitumor drug to human in the further.     

Lysosome‐targeted potent half‐sandwich iridium(III) α‐diimine antitumor complexes

Fifteen organometallic Ir(III) half‐sandwich complexes ( 1A – 5C ) having the general formula [(η⁵‐Cp^x)Ir(N^N)Cl]PF₆ (Cp^x = Cp*, tetramethyl(phenyl)cyclopentadienyl (Cp^xph) or tetramethyl(biphenyl)cyclopentadienyl (Cp^xbiph); N^N = diamine) have been synthesized and characterized. The molecular structure of 1A was determined using single‐crystal X‐ray diffraction analysis. The hydrolysis of 1A – 5C was monitored using UV–visible spectra. Complexes 3A – 3C showed catalytic activity for the oxidation of NADH to NAD⁺, where 3C showed the highest turnover number of 29.9 within 450 min. Cytotoxicity examination by MTT assay was carried out against two human cancer cell lines (HeLa and A549) after 24 or 48 h drug treatment. The complexes showed high potency, where the most potent complex ( 3C ; IC₅₀ = 3.4 μM) was six times more active than cisplatin against A549 cells after 24 h drug exposure. Cytotoxic potency towards A549 cells increased with phenyl substitution on Cp ring: Cp^xbiph > Cp^xph > Cp*. In addition, the biological studies showed that 3C caused cell apoptosis and cell cycle arrest at G₁ phase in A549 cancer cells. Moreover, 3C increased the level of reactive oxygen species markedly after 24 h, which may provide an important basis for killing cancer cells. Confocal laser scanning microscopy was used to track 3C in A549 cells. The cellular localization experiment showed that 3C targeted lysosomes and caused lysosomal damage.     

Synthesis,structure and antitumor activity of dibutyltin oxide complex with 5‐fluorouracil derivatives

The dibutyltin(IV) oxide complex reacts with 5‐fluorouracil‐l‐propanonic or5‐fluorouracil‐1‐acetic acid to give the potential antitumor activity complexes [(5‐fluorouracil)‐1‐(CH₂)_mCOOSn(Bu‐n)₂]₄O₂[m = 1, (1); m = 2, (2)] which were determined by IR and ¹H NMR. The crystal structure determination shows that complex 2 is a dimmer, in which two [(5‐fluorouracil)‐1‐CH₂CH₂COOSn(Bu‐n)₂]₂O units are linked by bridging oxygen atom, and the tin atoms adopt distorted trigonal bipyramids via two carbons from dibutyl group and three oxygen atoms from 5‐fluorouracil and bridging oxygen. In vitro test shows complexes 1 and 2 exhibit high cytotoxicity against OVCAR‐3 and PC‐14.     

DNA/BSA‐binding property and in vitro anticancer activity of a new dicopper(II) complex with N‐(2‐hydroxy‐5‐nitrophenyl)‐N′‐[3‐(diethylamino)propyl]oxamide as bridging ligand: Synthesis and crystal structure

A new oxamido‐bridged dicopper(II) complex formulated as [Cu₂(ndpox)(bpy)(CH₃OH)₂]‐ (ClO₄), where H₃ndpox is N‐(2‐hydroxy‐5‐nitrophenyl)‐N′‐[3‐(diethylamino)propyl]oxamide; and bpy represents 2,2′‐bipyridine, was synthesized and structurally characterized using X‐ray single‐crystal diffraction and other methods. In the molecule, the endo‐ and the exo‐copper(II) ions bridged by the cis ‐ndpox³⁻ ligand are in {N₃O₂} and {N₂O₃} square‐ pyramidal environments, respectively. There is a three‐dimensional hydrogen bonding network dominated by O‐H···O and C‐H···O interactions in the crystal. The reactivity toward DNA/protein bovine serum albumin (BSA) revealed that the complex could interact with herring sperm DNA (HS‐DNA) through the intercalation mode, and effectively quench the intrinsic fluorescence of BSA via a static process. Cytotoxicity studies suggest that the complex displays selective cancer cell antiproliferative activity. The present investigation confirmed that the combined effects of both electron‐withdrawing and hydrophobic groups on the bridging ligand in the dicopper(II) complex systems can increase DNA/BSA‐binding ability and in vitro anticancer activity.     

Synthesis and in vitro antitumor activity of some tetraphenylantimony derivatives of exo‐7‐oxa‐bicyclo[2,2,1] heptane (ene)‐3‐arylamide‐2‐acid

A series of novel tetraphenylantimony derivatives of exo‐7‐oxa‐bicyclo[2,2,1] heptane (ene)‐3‐arylamide‐2‐acid of the general formula Ph₄SbO₂CCHCHCH₂CH₂CH(O)HCONHAr (Ar = Ph,4‐ClC₆H₄, 4‐BrC₆H₄, 3‐BrC₆H₄, 4‐F‐3‐ClC₆H₃ and 4‐MeC₆H₄) have been synthesized and characterized by elemental analysis, IR, ¹H NMR and mass spectra. The crystal structure of Ph₄SbO₂CCHCHCH₂CH₂CH(O)HCONHC₆­H₄CH₃·CHCl₃ was determined by X‐ray diffraction. Five human neoplastic cell lines (HL‐60, KB, Bel‐7402, BGC‐823 and HCT‐8) were used to screen these compounds. The results indicate that these compounds at 10 µM show certain in vitro antitumor activities. Copyright © 2001 John Wiley & Sons, Ltd.     

Synthesis,Characterization, Cytotoxicity,and Hydrolytic Behavior of C2‐ and C1‐Symmetrical TiIV Complexes of Tetradentate Diamine Bis(Phenolato) Ligands: A New Class of Antitumor Agents

Carefully design your ligand! A new family of highly cytotoxic Ti^IV complexes demonstrates strong dependence of activity on the particular ligand employed, in which small structural modifications dramatically affect both hydrolytic behavior and biological activity (see picture). Different structure‐dependence patterns are observed for hydrolysis and cytotoxicity, which are, nonetheless, strongly related.

     

The dinuclear scandium(III) cyclooctatetraenyl chloride complex di‐μ‐chlorido‐bis[(η8‐cyclooctatetraene)(tetrahydrofuran‐κO)scandium(III)]

Only a few cyclooctatetraene dianion (COT) π‐complexes of lanthanides have been crystallographically characterized. This first single‐crystal X‐ray diffraction characterization of a scandium(III) COT chloride complex, namely di‐μ‐chlorido‐bis[(η⁸‐cyclooctatetraene)(tetrahydrofuran‐κO )scandium(III)], [Sc₂(C₈H₈)₂Cl₂(C₄H₈O)₂] or [Sc(COT)Cl(THF)]₂ (THF is tetrahydrofuran), (1), reveals a dimeric molecular structure with symmetric chloride bridges [average Sc—Cl = 2.5972 (7) Å] and a η⁸‐bound COT ligand. The COT ring is planar, with an average C—C bond length of 1.399 (3) Å. The Sc—C bond lengths range from 2.417 (2) to 2.438 (2) Å [average 2.427 (2) Å]. Direct comparison of (1) with the known lanthanide (Ln) analogues (La, Ce, Pr, Nd, and Sm) illustrates the effect of metal‐ion (M ) size on molecular structure. Overall, the M —Cl, M —O, and M —C bond lengths in (1) are the shortest in the series. In addition, only one THF molecule completes the coordination environment of the small Sc^III ion, in contrast to the previously reported dinuclear Ln–COT–Cl complexes, which all have two bound THF molecules per metal atom.     

A Novel Silver（Ⅰ）σ -Complex Supramolecular Polymer： [Ag2（o-HOPhCO2）2]n

The hydrothermal reactions of sodium o‐hydroxybenzoate with AgNO₃ yield a novel stable Ag(I) s?‐complex supramolecular polymer, [Ag₂(o‐HOPhCO₂)₂]_n. The structure of [Ag₂(o‐HOPhCO₂)₂] was solved by single crystal X‐ray diffraction analysis. It is monoclinic with space group P2Jc and unit cell parameters a=0.7394(2) nm, b= 0.8822(2) nm, c=1.0662(2) nm, β= 107.66(3)°, Z=4. The silver(I) atom is two‐coordinated by two carboxylic oxygen atoms of two o‐hydroxybenzoate ligands, and meanwhile, forms supramolecular interaction with one carbon atom of phenyl‐ring in the third o‐hydroxybenzoate group. The a‐form Ag…C supramolecular bond bridges [Ag₂(o‐HOPhCO₂)₂] units into an infinite 2D layered polymer [Ag₂(o‐HOPhCO₂)₂]_n. The coordination sphere of the silver atom is best described as a distorted T‐shaped geometry.     

meso‐(2‐Pyridyl)‐boron(III)‐subporphyrin: Perimeter Iridium(III) Coordination

Peripherally metalated porphyrinoids are promising functional π‐systems displaying characteristic optical, electronic, and catalytic properties. In this work, 5‐(2‐pyridyl)‐ and 5,10,15‐tri(2‐pyridyl)‐B^III‐subporphyrins were prepared and used to produce cyclometalated subporphyrins by reactions with [Cp*IrCl₂]₂, which proceeded through an efficient C?H activation to give the corresponding mono‐ and tri‐Ir^III complexes, respectively. While the mono‐Ir^III complex was obtained as a diastereomeric mixture, a C₃‐symmetric tri‐Ir^III complex with the three Cp*‐units all at the concave side was predominantly obtained in a high yield of 90 %, which displays weak NIR phosphorescence even at room temperature in degassed CH₂Cl₂, differently from the mono‐Ir^III complexes.     

Metal‐based antitumor,cytotoxic and antimicrobial activity: pharmacological evaluation of Knoevenagel condensate β‐diketone Schiff base thiosemicarbazone Cu(II) and Zn(II) complexes

Knoevenagel condensate Schiff base ligands [L = 3‐cinnamalideneacetylacetone‐thiosemicarbazone (CAT)/3‐cinnama‐ lideneacetylacetoneethylthiosemicarbazone (CAET)/3‐cinnamalideneacetylacetonephenylthiosemicarbazone (CAPT)] and their copper/zinc complexes were synthesized. They were characterized by analytical and spectral techniques. From these data it was found that the ligands adopt square‐planar geometry on metalation with Cu²⁺ and Zn²⁺. To evaluate the antitumor and cytotoxic activity of the synthesized complexes in mice and human cancer cell lines, the antitumor activity of the complexes was evaluated against an Ehrlich ascites carcinoma (EAC) tumor model. The activity was assessed using survival time and short‐term in vitro cytotoxic activity. Oral administration of complexes (100 mg/kg) increased the survival time. The cytotoxic activity of complexes was evaluated using human breast cancer (MDA‐MB‐231), colon cancer (HCT‐116) and nonsmall lung cancer (NCI‐H‐23) cell lines. Both the complexes possessed significant antitumor and cytotoxic activity on EAC and human cancer cell lines. The in vitro antimicrobial screening effect of the investigated compounds was also tested against the various organisms by well diffusion method. Copyright © 2009 John Wiley & Sons, Ltd.     

A pentanuclear bimetallic complex of manganese(II) and aluminium(III) ions: tetra‐μ2‐iodido‐iodidobis(μ3‐2‐methoxyethanolato)bis(μ2‐2‐methoxyethanolato)dimethyl(tetrahydrofuran‐κO)aluminium(III)tetramanganese(II)

The molecule of the title compound, [Mn₄Al(CH₃)₂(C₃H₇O₂)₄I₅(C₄H₈O)], contains one Al^III and four Mn^II ions. Two Mn atoms are five‐coordinate in the form of a trigonal bipyramid or a square pyramid. The two other Mn atoms are six‐coordinate with an octahedral geometry. The fourcoordinate Al atom is linked to the manganese core by μ‐O_alkoxo bridges, forming an almost planar five‐membered ring.     

A mixed‐valence iron complex of the antitumour drug 6‐mercaptopurine: tris(6‐mercaptopurine)iron(II) tetrachloroferrate(III) chloride

Single crystals of the title complex, tris(1,6‐di­hydro‐9H‐purine‐6‐thione‐N⁷,S)­iron(II) tetra­chloro­ferrate(III) chloride, [Fe(C₅H₄N₄S)₃][FeCl₄]Cl, were grown on the surface of solid 6‐mercaptopurine monohydrate pellets in a solution of iron(III) chloride. The solution of the hexagonal structure required the application of twin refinement techniques. All the component ions lie on threefold rotation axes. The complex contains distorted octahedral [Fe(C₅H₄N₄S)₃]²⁺ cations with three N7/S6‐chelating neutral 6‐mercaptopurine ligands, tetrahedral [FeCl₄]^? anions with a mean Fe—Cl distance of 2.189 (1) Å, and free chloride ions.     

A novel two‐dimensional cadmium(II) complex: poly[diaquatris(μ4‐cyclohexane‐1,4‐dicarboxylato)bis[2‐(pyridin‐4‐yl)‐1H‐benzimidazole]tricadmium(II)

The title compound, [Cd₃(C₈H₁₀O₄)₃(C₁₂H₉N₃)₂(H₂O)₂]_n or [Cd₃(chdc)₃(4‐PyBIm)₂(H₂O)₂]_n, was synthesized hydrothermally from the reaction of Cd(CH₃COO)₂·2H₂O with 2‐(pyridin‐4‐yl)‐1H‐benzimidazole (4‐PyBIm) and cyclohexane‐1,4‐dicarboxylic acid (1,4‐chdcH₂). The asymmetric unit consists of one and a half Cd^II cations, one 4‐PyBIm ligand, one and a half 1,4‐chdc²⁻ ligands and one coordinated water molecule. The central Cd^II cation, located on an inversion centre, is coordinated by six carboxylate O atoms from six 1,4‐chdc²⁻ ligands to complete an elongated octahedral coordination geometry. The two terminal rotationally symmetric Cd^II cations each exhibits a distorted pentagonal–bipyramidal geometry, coordinated by one N atom from 4‐PyBIm, five O atoms from three 1,4‐chdc²⁻ ligands and one O atom from an aqua ligand. The 1,4‐chdc²⁻ ligands possess two conformations, i.e.e,e‐trans‐chdc²⁻ and e,a‐cis‐chdc²⁻. The cis‐1,4‐chdc²⁻ ligands bridge the Cd^II cations to form a trinuclear {Cd₃}‐based chain along the b axis, while the trans‐1,4‐chdc²⁻ ligands further link adjacent one‐dimensional chains to construct an interesting two‐dimensional network.     

[Mn4Br(CH=CMe2)3(μ3‐NPEt3)4] — ein 2‐Methyl‐prop‐1‐enyl‐Phosphaniminato‐Komplex von Mangan(II) mit Heterokubanstruktur

[Mn₄Br(CH=CMe₂)₃(μ₃‐NPEt₃)₄] — a 2‐Methyl‐prop‐1‐enyl‐Phosphoraneiminato Complex of Manganese(II) with Heterocubane Structure [Mn₄Br(CH=CMe₂)₃(μ₃‐NPEt₃)₄] ( 1 ) has been prepared from [MnBr(μ₃‐NPEt₃)]₄ and BrMg(CH=CMe₂) in thf solution and subsequent extraction of the solvent‐free residue with n‐hexane. 1 forms red single crystals from diethylether solution, which are characterized by a crystal structure determination. Space group P1¯, Z = 2, lattice dimensions at —80 °C: a = 1144.7(1), b = 1411.3(2), c = 1521.8(2) pm, α = 91.581(14), β = 90.163(14), γ = 91.947(14)°, R₁ = 0.0448. 1 exhibits a Mn₄N₄ heterocubane core, a terminally coordinated bromine ligand and three Mn—CH=CMe₂ groups with M—C bond lengths of 213.8 pm on average.     

Spectroscopic and electrochemical study for evaluating DNA interaction activity of 4‐(3‐halophenyl)‐6‐(pyridin‐2‐yl)pyrimidin‐2‐amine based piano stool Cp* Rh (III) and Ir (III) complexes

Six novel organometallic half sandwich complexes [(η5‐C₅Me₅)M(L^1–3)Cl]Cl.2H₂O were synthesized using [{(η⁵‐C₅Me₅)M(μ‐Cl)Cl₂], where M = Ir (III)/Rh (III) and L^1–3 = three pyridyl pyrimidine based ligands; and characterized by NMR, Infra‐red spectroscopy, conductance, elemental and thermal analysis. The complex‐DNA binding mode and/or strength evaluated using absorption titration, electrochemical studies and hydrodynamic measurement proposed intercalative binding mode, which was also confirmed by molecular docking study. Differential pulse voltammetry and cyclic voltammetry studies indicated an alteration in oxidation and reduction potentials of complexes (M⁺⁴/M⁺³) in presence of CT‐DNA. The metal complexes can cleave plasmid DNA as proposed in gel electrophoretic analysis. The LC₅₀ values of complexes evaluated on brine shrimp suggested their potent cytotoxic nature.     

新癌药物的电化学研究1: 一种Fe(III) Schiff碱配合物的基本电化学性质及其与DNA的相互作用

研究了一种自合成的Schiff碱配合物的电化学行为及其与氧和DNA的相互作用。发现此种Schiff碱配合物能与氧发生相互作用而具有吸氧功能, 并对氧的电还原有催化作用, 同时还发现dsDNA能与此种Schiff碱配合物发生较强的相互作用, 特别是Fe(II)Schiff碱配合物更易与dsDNA结合。     

A new complex of HgBr2 and pyrimidine‐2‐thione: (pyrimidine‐2‐thionato‐κS)(pyrimidinium‐2‐thionato‐κS)mercury(II) tetrabromomercury(II)

The title compound, [Hg(C₄H₄N₂S)(C₄H₃N₂S)]₂[HgBr₄], con­sists of [Hg(pymt)(pymtH)]⁺ complex cations (pymtH is pyrimidine‐2‐thione) lying across twofold rotation axes in space group Fddd, with linearly coordinated mercury at an Hg—S distance of 2.357 (3) Å, and [HgBr₄]²⁻ anions lying at sites of 222 symmetry. The Hg atom is additionally coordinated by two N and two Br atoms, forming a 2+4 effective coordination sphere. The protonated ligand is connected via N—H⋯N hydrogen bonds to the neighbouring unprotonated ligand, thus forming infinite chains of cations.     

Structural studies and cytotoxic activity of a new dinuclear coordination compound of palladium(II)–2,2′:6′,2″‐terpyridine with rigid dianionic 1,2,4‐triazole‐3‐sulfonate linker

A new dinuclear coordination compound of palladium(II), [Pd₂(terpy)₂(μ‐tas‐N¹,N⁴)]SO₄?11H₂O ( 1 ), was synthesized by tethering a doubly deprotonated 1,2,4‐triazole‐3‐sulfonate (tas) linker generated in situ via oxidation of 1,2,4‐triazole‐3‐thione (tat) under the synthetic conditions. X‐ray diffraction analysis reveals that tat molecules adopt the thione form in the solid state, and are combined in infinite chains by symmetrically related classical intermolecular hydrogen bonds N1─H1???S1, N3─H3???N2 to give rise to R₂²(7) pattern in one‐dimensional chains along the b‐axis propagating along the a‐axis. Further short contacts through lone pairs of N2???S1 on the rings between the adjacent chains along the a‐axis lead to a two‐dimensional network structure. Compound 1 was characterized using infrared, ¹H NMR and UV–visible spectroscopies, electrospray ionization mass spectrometry and X‐ray crystallography. The crystal structure determination of 1 reveals that the Pd(II) ions are coordinated with four nitrogen atoms: three from terpy and one from tas acting as an end‐to‐end (μ‐1,4) bridging ligand. The Pd(II) ions in 1 adopt a distorted square planar geometry. The anti‐growth effect of 1 was tested on colorectal cancer (HCT‐15), non‐small‐cell lung cancer (A549), prostate cancer (PC‐3) and cervical cancer (HeLa) cell lines using sulforhodamine B viability assay. The cytotoxic effect was further confirmed using adenosine triphosphate viability assay. Compound 1 shows a promising cytotoxic activity in the diverse cancer cell models in vitro (p <0.0001).     

Amido‐3‐hydroxypyridin‐4‐ones as Iron(III) Ligands

The synthesis and physicochemical properties of a range of 2‐ and 6‐amido‐3‐hydroxypyridin‐4‐ones are described. All the amido‐substituted 3‐hydroxypyridin‐4‐ones have lower pK_a values than 1,2‐dimethyl‐3‐hydroxypyridin‐4‐one (deferiprone). This is due to the inductive effect of the amido group. Furthermore, the pK_a values of the 3‐hydroxy group in 1‐nonsubstituted pyridinones are dramatically lower than those of the corresponding 1‐alkyl analogues, indicating that a strong hydrogen bond exists between the 2‐amido function and the 3‐oxygen anion, which stabilises the anion. As a result of the decreased competition with protons, the pFe³⁺ values of this group of molecules are higher than that of deferiprone. The distribution coefficients of these molecules are also increased despite the lack of a hydrophobic 1‐alkyl substituent and this is ascribed to the intramolecular hydrogen bond. X‐ray diffraction studies confirm the existence of the intramolecular hydrogen bond.